anurajms/meta_analysis huggingface dataset:
Provide patient population that should be included in the study
Daclizumab for relapsing remitting multiple sclerosis
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Relapsing Remitting Multiple Sclerosis 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Pharmacological treatment for memory disorder in multiple sclerosis
1. Aged 80 and over 80+ years 2. Multiple Sclerosis 3. Adult 19-44 years 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Memory Impairment 7. Aged 65-79 years
Provide patient population that should be included in the study
Rituximab for relapsing‐remitting multiple sclerosis
1. Aged 80 and over 80+ years 2. Multiple Sclerosis 3. Adult 19-44 years 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Non‐antiepileptic drugs for trigeminal neuralgia
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Trigeminal Neuralgia
Provide patient population that should be included in the study
Lamotrigine for chronic neuropathic pain and fibromyalgia in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Fibromyalgia 6. Chronic central neuropathic pain 7. Aged 65-79 years 8. Multiple chronic conditions
Provide patient population that should be included in the study
Naproxen with or without an antiemetic for acute migraine headaches in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Migraine 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Thymectomy for non‐thymomatous myasthenia gravis
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Young Adult 19-24 years 7. Aged 65-79 years 8. Myasthenia Gravis 9. Adolescent 13-18 years
Provide patient population that should be included in the study
Physiotherapy versus placebo or no intervention in Parkinson's disease
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Parkinson's Disease 6. Aged 65-79 years
Provide patient population that should be included in the study
Botulinum toxin for masseter hypertrophy
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Hypertrophy Of Masseter Muscle 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Topiramate for neuropathic pain and fibromyalgia in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Chronic central neuropathic pain 6. Aged 65-79 years
Provide patient population that should be included in the study
Nonoperative treatment for lumbar spinal stenosis with neurogenic claudication
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Neurogenic Claudication Co-occurrent And Due To Spinal Stenosis Of Lumbar Region 6. Aged 65-79 years
Provide patient population that should be included in the study
Triptans for acute cluster headache
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Cluster Headache 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Antiepileptic drugs for the primary and secondary prevention of seizures after subarachnoid haemorrhage
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Subarachnoid Hemorrhage 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Therapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron disease
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Amyotrophic Lateral Sclerosis 5. Motor Neuron Disease 6. Young Adult 19-24 years 7. Aged 65-79 years
Provide patient population that should be included in the study
Mitoxantrone for multiple sclerosis
1. Aged 80 and over 80+ years 2. Multiple Sclerosis 3. Adult 19-44 years 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Paracetamol (acetaminophen) with or without an antiemetic for acute migraine headaches in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Migraine 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Aspirin with or without an antiemetic for acute migraine headaches in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Migraine 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Diclofenac with or without an antiemetic for acute migraine headaches in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Migraine 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Ibuprofen with or without an antiemetic for acute migraine headaches in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Migraine 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Drug therapy for preventing post‐dural puncture headache
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Lumbar Puncture 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Intravenous immunoglobulin for myasthenia gravis
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Young Adult 19-24 years 7. Myasthenia Gravis With Exacerbation 8. Aged 65-79 years 9. Myasthenia Gravis 10. Adolescent 13-18 years
Provide patient population that should be included in the study
Cognitive behavioural therapy (CBT) with and without exercise to reduce fear of falling in older people living in the community
1. Aged 80 and over 80+ years 2. Middle Aged 45-64 years 3. Fear Of Falling 4. Aged 65-79 years
Provide patient population that should be included in the study
Hypothermia for neuroprotection in adults after cardiac arrest
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Cardiac Arrest With Successful Resuscitation 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Environmental interventions for preventing falls in older people living in the community
1. Aged 80 and over 80+ years 2. Middle Aged 45-64 years 3. Aged 65-79 years
Provide patient population that should be included in the study
Systemic corticosteroids for radicular and non‐radicular low back pain
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Spinal Stenosis 4. Low back pain 5. Young Adult 19-24 years
Provide patient population that should be included in the study
Peripheral nerve blocks for hip fractures in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Hip Fracture 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Shoulder replacement surgery for osteoarthritis and rotator cuff tear arthropathy
1. Adult 19-44 years 2. Primary Localized Osteoarthrosis Of Shoulder Region 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Rotator Cuff Tear Arthropathy 6. Arthritis Of Shoulder Region Joint 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Shock wave therapy for rotator cuff disease with or without calcification
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Disorder Of Rotator Cuff
Provide patient population that should be included in the study
Prophylactic antibiotics for penetrating abdominal trauma
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Penetrating abdominal trauma 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Pregabalin for neuropathic pain in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Neuropathic Pain 6. Aged 65-79 years 7. Adolescent 13-18 years 8. Chronic Pain
Provide patient population that should be included in the study
Multifactorial and multiple component interventions for preventing falls in older people living in the community
1. Aged 80 and over 80+ years 2. Middle Aged 45-64 years 3. At Risk For Falls 4. Aged 65-79 years
Provide patient population that should be included in the study
One‐incision versus two‐incision techniques for arthroscopically assisted anterior cruciate ligament reconstruction in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Anterior Cruciate Ligament Tear 6. Aged 65-79 years
Provide patient population that should be included in the study
Neuromuscular electrical stimulation (NMES) for patellofemoral pain syndrome
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Patellofemoral Pain Syndrome 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Antiseptics for burns
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Burn 4. Adult 19-44 years 5. Child 6-12 years 6. Middle Aged 45-64 years 7. Infant 1 to 23 mo 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Wound 11. Aged 65-79 years 12. Adolescent 13-18 years
Provide patient population that should be included in the study
Desmopressin use for minimising perioperative blood transfusion
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Invasive Procedure 7. Infant 1 to 23 mo 8. Surgery 9. Young Adult 19-24 years 10. Birth to 1 mo 11. Aged 65-79 years 12. Adolescent 13-18 years
Provide patient population that should be included in the study
Injected corticosteroids for treating plantar heel pain in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Plantar Heel Pain 6. Aged 65-79 years
Provide patient population that should be included in the study
Single dose oral ketoprofen or dexketoprofen for acute postoperative pain in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Postoperative Pain 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Capnography versus standard monitoring for emergency department procedural sedation and analgesia
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Child 6-12 years 4. Infant 1 to 23 mo 5. Sedated 6. Aged 65-79 years 7. Adolescent 13-18 years 8. Adult 19-44 years 9. Analgesia 10. Emergency Care 11. Middle Aged 45-64 years 12. Young Adult 19-24 years 13. Birth to 1 mo
Provide patient population that should be included in the study
Interventions for treating simple bone cysts in the long bones of children
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Bone Cyst 4. Adolescent 13-18 years
Provide patient population that should be included in the study
Liposomal bupivacaine infiltration at the surgical site for the management of postoperative pain
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Postoperative Pain 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
School‐based education programmes for the prevention of unintentional injuries in children and young people
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Adolescence 4. Childhood 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Pharmacologic interventions for treating phantom limb pain
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Phantom Limb Pain 7. Infant 1 to 23 mo 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Antifibrinolytic agents for reducing blood loss in scoliosis surgery in children
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Surgery 4. Scoliosis Deformity Of Spine 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Liposomal bupivacaine peripheral nerve block for the management of postoperative pain
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Postoperative Pain 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Technological aids for the rehabilitation of memory and executive functioning in children and adolescents with acquired brain injury
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Infant 1 to 23 mo 4. Acquired Brain Injury 5. Young Adult 19-24 years 6. Birth to 1 mo 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Single dose intravenous paracetamol or intravenous propacetamol for postoperative pain
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Postoperative Pain 6. Middle Aged 45-64 years 7. Infant 1 to 23 mo 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Single dose intra‐articular morphine for pain control after knee arthroscopy
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Postoperative Pain 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Vapocoolants (cold spray) for pain treatment during intravenous cannulation
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Aged 65-79 years 10. Intravenous Catheter Management 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Single dose dipyrone (metamizole) for acute postoperative pain in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Postoperative Pain 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Interventions for treating ankle fractures in children
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Infant 1 to 23 mo 4. Ankle fracture 5. Birth to 1 mo 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Perioperative fluid volume optimization following proximal femoral fracture
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Regional Anesthesia 4. Middle Aged 45-64 years 5. Surgery 6. Young Adult 19-24 years 7. Fracture Of Proximal End Of Femur 8. General Anesthesia 9. Aged 65-79 years
Provide patient population that should be included in the study
Anaesthesia for hip fracture surgery in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Surgery 5. Young Adult 19-24 years 6. Hip Fracture 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Surgical versus non‐surgical treatment for lumbar spinal stenosis
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Lumbar Spinal Stenosis
Provide patient population that should be included in the study
Helicopter emergency medical services for adults with major trauma
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Trauma 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Knee orthoses for treating patellofemoral pain syndrome
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Patellofemoral Pain Syndrome 7. Infant 1 to 23 mo 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Manipulation and mobilisation for neck pain contrasted against an inactive control or another active treatment
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Adolescent 13-18 years 5. Neck Pain
Provide patient population that should be included in the study
Whole‐body cryotherapy (extreme cold air exposure) for preventing and treating muscle soreness after exercise in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Muscular Pain 6. Physical Exercises 7. Aged 65-79 years
Provide patient population that should be included in the study
Hemodialysis for lithium poisoning
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Aged 65-79 years 10. Adolescent 13-18 years 11. Lithium Poisoning
Provide patient population that should be included in the study
Emergency ultrasound‐based algorithms for diagnosing blunt abdominal trauma
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Hemodynamic Instability 6. Hemodynamically Stable 7. Aged 65-79 years
Provide patient population that should be included in the study
Surgical versus nonsurgical interventions for flail chest
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Flail Chest 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Steroidal contraceptives and bone fractures in women: evidence from observational studies
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years
Provide patient population that should be included in the study
Single dose oral diclofenac for acute postoperative pain in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Postoperative Pain 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Prothrombin complex concentrate for reversal of vitamin K antagonist treatment in bleeding and non‐bleeding patients
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Child 6-12 years 4. Infant 1 to 23 mo 5. Aged 65-79 years 6. Adolescent 13-18 years 7. Adult 19-44 years 8. Middle Aged 45-64 years 9. Surgery 10. Young Adult 19-24 years 11. Birth to 1 mo 12. Vitamin K Allergy 13. Haemorrhage
Provide patient population that should be included in the study
Patient controlled opioid analgesia versus non‐patient controlled opioid analgesia for postoperative pain
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Postoperative Pain 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Injection therapies for Achilles tendinopathy
1. Aged 80 and over 80+ years 2. Achilles Tendinitis 3. Adult 19-44 years 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Antifibrinolytic drugs for acute traumatic injury
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Child 6-12 years 4. Infant 1 to 23 mo 5. Trauma 6. Aged 65-79 years 7. Adolescent 13-18 years 8. Adult 19-44 years 9. Middle Aged 45-64 years 10. Traumatic Brain Injury 11. Young Adult 19-24 years 12. Birth to 1 mo 13. Haemorrhage
Provide patient population that should be included in the study
Sweet tasting solutions for reduction of needle‐related procedural pain in children aged one to 16 years
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Infant 1 to 23 mo 4. Procedural Pain 5. Needle Stick/puncture 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Corticosteroids for the management of cancer‐related pain in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Cancer Pain 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Surgical versus non‐surgical interventions in people with adolescent idiopathic scoliosis
1. Child 6-12 years 2. Adolescent Idiopathic Scoliosis 3. Adolescent 13-18 years
Provide patient population that should be included in the study
Red blood cell transfusion for people undergoing hip fracture surgery
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Hip Fracture 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Surgical interventions for treating distal tibial metaphyseal fractures in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Tibia fracture
Provide patient population that should be included in the study
Tramadol for postoperative pain treatment in children
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Postoperative Pain 4. Infant 1 to 23 mo 5. Birth to 1 mo 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Effectiveness of posterior decompression techniques compared with conventional laminectomy for lumbar stenosis
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Degenerative Lumbar Spinal Stenosis 4. Young Adult 19-24 years
Provide patient population that should be included in the study
As required versus fixed schedule analgesic administration for postoperative pain in children
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Postoperative Pain 4. Infant 1 to 23 mo 5. Birth to 1 mo 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Single dose oral ibuprofen plus codeine for acute postoperative pain in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Acute Postoperative Pain 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Cell salvage in emergency trauma surgery
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Surgery 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Trauma 11. Aged 65-79 years 12. Adolescent 13-18 years
Provide patient population that should be included in the study
Exercise for treating patellofemoral pain syndrome
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Patellofemoral Pain Syndrome 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Single induction dose of etomidate versus other induction agents for endotracheal intubation in critically ill patients
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Critical Illness 9. Birth to 1 mo 10. Aged 65-79 years 11. Endotracheal intubation 12. Adolescent 13-18 years
Provide patient population that should be included in the study
Iron therapy in anaemic adults without chronic kidney disease
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Anemia 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Isotonic versus hypotonic solutions for maintenance intravenous fluid administration in children
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Infant 1 to 23 mo 4. Administration Of Intravenous Fluids 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Exercise for reducing fear of falling in older people living in the community
1. Aged 80 and over 80+ years 2. Fear Of Falling 3. Aged 65-79 years
Provide patient population that should be included in the study
Salicylate‐containing rubefacients for acute and chronic musculoskeletal pain in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Musculoskeletal Pain 6. Aged 65-79 years
Provide patient population that should be included in the study
Intravenous lidocaine for the treatment of background or procedural burn pain
1. Aged 80 and over 80+ years 2. Burn 3. Adult 19-44 years 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Advanced trauma life support training for hospital staff
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Trauma 6. Aged 65-79 years
Provide patient population that should be included in the study
Oral or parenteral iron supplementation to reduce deferral, iron deficiency and/or anaemia in blood donors
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Blood Donor 5. Aged 65-79 years 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Steroidal contraceptives: effect on bone fractures in women
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Bone Density 4. Young Adult 19-24 years 5. Menopause 6. Fracture
Provide patient population that should be included in the study
Femoral nerve blocks for acute postoperative pain after knee replacement surgery
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Total knee arthroplasty 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Single dose oral etoricoxib for acute postoperative pain in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Acute Postoperative Pain 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Interventions for treating fingertip entrapment injuries in children
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Finger injury
Provide patient population that should be included in the study
Hip protectors for preventing hip fractures in older people
1. Aged 80 and over 80+ years 2. Hip Fracture 3. Aged 65-79 years
Provide patient population that should be included in the study
Selective computed tomography (CT) versus routine thoracoabdominal CT for high‐energy blunt‐trauma patients
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. High-energy trauma
Provide patient population that should be included in the study
The Lund concept for severe traumatic brain injury
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Traumatic Brain Injury 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Hyperbaric oxygen therapy for treating acute surgical and traumatic wounds
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Wound 6. Aged 65-79 years
Provide patient population that should be included in the study
Single dose oral dexibuprofen [S(+)‐ibuprofen] for acute postoperative pain in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Postoperative Pain 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Primary closure versus delayed closure for non bite traumatic wounds within 24 hours post injury
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Young Adult 19-24 years 7. Wound 8. Aged 65-79 years 9. Adolescent 13-18 years
Provide patient population that should be included in the study
Single dose oral celecoxib for acute postoperative pain in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Postoperative Pain 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Antibiotics for treating chronic osteomyelitis in adults
1. Aged 80 and over 80+ years 2. Osteomyelitis 3. Adult 19-44 years 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Antipsychotics for acute and chronic pain in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Acute Pain 6. Aged 65-79 years 7. Adolescent 13-18 years 8. Chronic Pain
Provide patient population that should be included in the study
Opioids compared to placebo or other treatments for chronic low‐back pain
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Chronic Low Back Pain 6. Aged 65-79 years
Provide patient population that should be included in the study
Electrotherapy for neck pain
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Neck Pain
Provide patient population that should be included in the study
Single dose oral tenoxicam for acute postoperative pain in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Acute Postoperative Pain
Provide patient population that should be included in the study
Physical activity and education about physical activity for chronic musculoskeletal pain in children and adolescents
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Musculoskeletal Pain 4. Adolescent 13-18 years
Provide patient population that should be included in the study
Automated mandatory bolus versus basal infusion for maintenance of epidural analgesia in labour
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Pregnancy 6. Aged 65-79 years
Provide patient population that should be included in the study
Physiotherapy for pain and disability in adults with complex regional pain syndrome (CRPS) types I and II
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Complex Regional Pain Syndrome 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Implanted spinal neuromodulation interventions for chronic pain in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Headache 4. Middle Aged 45-64 years 5. Migraine 6. Young Adult 19-24 years 7. Aged 65-79 years 8. Adolescent 13-18 years 9. Chronic Pain
Provide patient population that should be included in the study
Single‐dose intravenous ibuprofen for acute postoperative pain in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Acute Postoperative Pain 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Single‐dose intravenous ketorolac for acute postoperative pain in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Postoperative Pain 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Non‐steroidal anti‐inflammatory drugs (NSAIDs) for trigger finger
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Trigger finger 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Relief of pain due to uterine cramping/involution after birth
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Vaginal Delivery 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Psychological therapies for the management of chronic pain (excluding headache) in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Migraine 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years 8. Chronic Pain
Provide patient population that should be included in the study
Topical anaesthesia plus intracameral lidocaine versus topical anaesthesia alone for phacoemulsification cataract surgery in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Phacoemulsification 6. Aged 65-79 years
Provide patient population that should be included in the study
Early enteral nutrition (within 48 hours) versus delayed enteral nutrition (after 48 hours) with or without supplemental parenteral nutrition in critically ill adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Enteral nutrition 5. Young Adult 19-24 years 6. Intensive Care 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Adductor canal blocks for postoperative pain treatment in adults undergoing knee surgery
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Knee surgery 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Bispectral index for improving intraoperative awareness and early postoperative recovery in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Surgery 5. Young Adult 19-24 years 6. General Anesthesia 7. Aged 65-79 years
Provide patient population that should be included in the study
Perioperative intravenous ketamine for acute postoperative pain in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Postoperative Pain 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Pre‐emptive and preventive opioids for postoperative pain in adults undergoing all types of surgery
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Surgery 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Adverse side effects of dexamethasone in surgical patients
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Surgery 5. Young Adult 19-24 years 6. Administration Of Anesthesia 7. Aged 65-79 years
Provide patient population that should be included in the study
Maternal position in the second stage of labour for women with epidural anaesthesia
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Epidural Analgesia 4. Young Adult 19-24 years 5. Pregnancy 6. Second stage of labor 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Single‐dose intravenous diclofenac for acute postoperative pain in adults
1. Adult 19-44 years 2. Postoperative Pain 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Intravenous versus inhalational maintenance of anaesthesia for postoperative cognitive outcomes in elderly people undergoing non‐cardiac surgery
1. Aged 80 and over 80+ years 2. Middle Aged 45-64 years 3. Surgery 4. General Anesthesia 5. Aged 65-79 years
Provide patient population that should be included in the study
Mirtazapine for fibromyalgia in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Fibromyalgia 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Enteral versus parenteral nutrition and enteral versus a combination of enteral and parenteral nutrition for adults in the intensive care unit
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Critical Illness 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Melatonin for the promotion of sleep in adults in the intensive care unit
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Critical Illness 6. Intensive Care 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Cannabis‐based medicines for chronic neuropathic pain in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Neuropathic Pain 6. Aged 65-79 years 7. Adolescent 13-18 years 8. Chronic Pain
Provide patient population that should be included in the study
Alpha‐2 adrenergic agonists for the prevention of cardiac complications among adults undergoing surgery
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Surgery 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Use of hyaluronidase as an adjunct to local anaesthetic eye blocks to reduce intraoperative pain in adults
1. Aged 80 and over 80+ years 2. Eye 3. Adult 19-44 years 4. Middle Aged 45-64 years 5. Surgery 6. Young Adult 19-24 years 7. Aged 65-79 years
Provide patient population that should be included in the study
Cerebral near‐infrared spectroscopy (NIRS) for perioperative monitoring of brain oxygenation in children and adults
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Child 6-12 years 4. Infant 1 to 23 mo 5. Local Anesthesia 6. Aged 65-79 years 7. Adolescent 13-18 years 8. Adult 19-44 years 9. Middle Aged 45-64 years 10. Surgery 11. Young Adult 19-24 years 12. Birth to 1 mo 13. General Anesthesia
Provide patient population that should be included in the study
Propofol for the promotion of sleep in adults in the intensive care unit
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Critical Illness 6. Intensive Care 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Oxcarbazepine for neuropathic pain
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Neuropathic Pain 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Cuffed versus uncuffed endotracheal tubes for general anaesthesia in children aged eight years and under
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Infant 1 to 23 mo 4. Birth to 1 mo 5. General Anesthesia
Provide patient population that should be included in the study
Dexamethasone as an adjuvant to peripheral nerve block
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Limb operation 9. Aged 65-79 years 10. Adolescent 13-18 years
Provide patient population that should be included in the study
Nerve blocks or no nerve blocks for pain control after elective hip replacement (arthroplasty) surgery in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Total hip replacement 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Heat and moisture exchangers versus heated humidifiers for mechanically ventilated adults and children
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Mechanical ventilation 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Harms of off‐label erythropoiesis‐stimulating agents for critically ill people
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Young Adult 19-24 years 7. Critical Illness 8. Aged 65-79 years 9. Adolescent 13-18 years
Provide patient population that should be included in the study
Interventions for treating persistent pain in survivors of torture
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Torture 10. Aged 65-79 years 11. Adolescent 13-18 years 12. Chronic Pain
Provide patient population that should be included in the study
Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Elective Surgery 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Antidepressants for chronic non‐cancer pain in children and adolescents
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Infant 1 to 23 mo 4. Birth to 1 mo 5. Adolescent 13-18 years 6. Chronic Pain
Provide patient population that should be included in the study
Antiepileptic drugs for chronic non‐cancer pain in children and adolescents
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Infant 1 to 23 mo 4. Chronic Nonmalignant Pain 5. Birth to 1 mo 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Non‐steroidal anti‐inflammatory drugs (NSAIDs) for chronic non‐cancer pain in children and adolescents
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Infant 1 to 23 mo 4. Birth to 1 mo 5. Adolescent 13-18 years 6. Chronic Pain
Provide patient population that should be included in the study
Paracetamol (acetaminophen) for chronic non‐cancer pain in children and adolescents
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Infant 1 to 23 mo 4. Birth to 1 mo 5. Adolescent 13-18 years 6. Chronic Pain
Provide patient population that should be included in the study
Opioids for chronic non‐cancer pain in children and adolescents
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Infant 1 to 23 mo 4. Chronic Nonmalignant Pain 5. Birth to 1 mo 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Videolaryngoscopy versus direct laryngoscopy for tracheal intubation in children (excluding neonates)
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Emergency Care 4. Infant 1 to 23 mo 5. Elective Procedure 6. Intubation 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Morphine for chronic neuropathic pain in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Neuropathic Pain 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Methadone for neuropathic pain in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Neuropathic Pain 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Total intravenous anaesthesia versus inhalational anaesthesia for adults undergoing transabdominal robotic assisted laparoscopic surgery
1. Aged 80 and over 80+ years 2. Laparoscopic Surgery 3. Adult 19-44 years 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Oral nonsteroidal anti‐inflammatory drugs for fibromyalgia in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Fibromyalgia 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Topical anaesthetics for pain control during repair of dermal laceration
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Laceration Of Skin 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Wound Closure 11. Aged 65-79 years 12. Adolescent 13-18 years
Provide patient population that should be included in the study
Gabapentin for fibromyalgia pain in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Fibromyalgia 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Paracetamol (acetaminophen) with or without codeine or dihydrocodeine for neuropathic pain in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Neuropathic Pain 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Intravenous nutrients for preventing inadvertent perioperative hypothermia in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Surgery 5. Young Adult 19-24 years 6. Administration Of Anesthesia 7. Aged 65-79 years
Provide patient population that should be included in the study
Recruitment manoeuvres for adults with acute respiratory distress syndrome receiving mechanical ventilation
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Acute Respiratory Distress 5. Young Adult 19-24 years 6. Intubation 7. Intensive Care 8. Mechanical ventilation 9. Aged 65-79 years
Provide patient population that should be included in the study
Breastfeeding for procedural pain in infants beyond the neonatal period
1. Infant 1 to 23 mo 2. Procedural Pain
Provide patient population that should be included in the study
Anaesthetic interventions for prevention of awareness during surgery
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Surgery 8. Young Adult 19-24 years 9. Aged 65-79 years 10. Adolescent 13-18 years
Provide patient population that should be included in the study
Deliberate hypotension with propofol under anaesthesia for functional endoscopic sinus surgery (FESS)
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Functional Endoscopic Sinus Surgery 6. Middle Aged 45-64 years 7. Infant 1 to 23 mo 8. Young Adult 19-24 years 9. Birth to 1 mo 10. General Anesthesia 11. Aged 65-79 years 12. Adolescent 13-18 years
Provide patient population that should be included in the study
Fentanyl for neuropathic pain in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Neuropathic Pain 6. Aged 65-79 years 7. Adolescent 13-18 years 8. Chronic Pain
Provide patient population that should be included in the study
Hyperbaric versus isobaric bupivacaine for spinal anaesthesia for caesarean section
1. Adult 19-44 years 2. Cesarean Section 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Pregnancy 6. Adolescent 13-18 years